Summary
Updated Aug 31, 2026
Jeffrey T. L. Smith is EVP & Chief Medical Officer of Zymeworks Inc. (ZYME). 2 SEC Form 4 filings on record, most recently on 13 January 2026. Most recent open-market trade: sold $211K of ZYME on 13 January 2026. Lifetime open-market sales: $476K.
Recent Transactions
4Every recent SEC Form 4 transaction Jeffrey T. L. Smith has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Jeffrey T. L. Smith go back to 2026: 2 primary Form 4 filings, an average of 2.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Jeffrey T. L. Smith files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Kenneth Galbraith - $3.34M of ZYME open-market activity in the last 12 months
- Paul Andrew Moore - $721K of ZYME open-market activity in the last 12 months
- Mark Hollywood - $139K of ZYME open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Jeffrey T. L. Smith?
Jeffrey T. L. Smith is a corporate insider, tracked as EVP & Chief Medical Officer of Zymeworks Inc. (ZYME). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Jeffrey T. L. Smith last file a Form 4?
The most recent primary Form 4 on record is dated 13 January 2026, one of 2 filings going back to 2026.
Has Jeffrey T. L. Smith been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($476K) across all tracked filings.
Where can I see all of Jeffrey T. L. Smith's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Jeffrey T. L. Smith and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial